Intuitive's strong quarter
- Revenue: 806.1 (+6.6%); Systems: 258.1 (+19.3%); Services: 146.8 (+3.4%).
- Net Income: 297.5 (+34.3%); Non-GAAP Net Income: 323.8 (+41.8%); EPS: 2.55 (+32.8%); Non-GAAP EPS: 2.77 (+39.9%).
- Global da Vinci procedures up 15%.
- Total da Vinci shipments: 169 (+26%)
- ISRG stocks are up to 370+, wich means 1100+ before the 3:1 stock split they made
"Intuitive Surgical has a strong case for growth. The market for surgical procedures is a complex array to define, but as a starter, the cosmetic surgery and procedure annual market alone is expected to reach $43.9 billion by 2025. The global market for cardiovascular surgical devices is expected to grow from $37.0 billion in 2015 to $57.2 billion in 2020 with a CAGR of 9.4% from 2015-2020. Robotic and computer-assisted surgeries are gradually gaining market share in the surgical market space, and it is just getting started. It is estimated that by 2020 the annual market for robotic surgery will rise to $6 billion, up from $3 billion in 2014, with a CAGR of over 10%. More specifically, the robotic urological surgery market is expected to reach $3.3 billion by 2025. Robotic endometrial ablation market will reach $1.3 billion by 2024. Gastrointestinal surgery market is expected to reach $1.4 billion by 2025. Moreover, the global medical robotics market is expected to reach $17.5 billion by 2023, growing at a 22% CAGR from 2017-2023. Strong Bio believes these market estimates should provide more than enough evidence that ISRG has plenty of room to grow. As worldwide technological growth fuels innovation and better quality patient care, it's clear to see why Strong Bio is considering a position in ISRG. In addition, the body of 13,500 scientific and medical research journal compositions citing utilization of robotic surgery has grown year over year since 2005."
Source: Yahoo, SeekingAlpha